Skip to main content
Vor Biopharma Inc. logo

Vor Biopharma Inc. — Investor Relations & Filings

Ticker · VOR ISIN · US9290331084 US Professional, scientific and technical activities
Open in API
Filings indexed 406 across all filing types
Latest filing 2021-02-02 Regulatory Filings
Country US United States of America
Listing US VOR

About Vor Biopharma Inc.

https://www.vorbio.com/

Vor Biopharma Inc. is a clinical-stage biotechnology company focused on developing treatments for autoimmune diseases. The company is committed to advancing medicines that target the fundamental drivers of autoimmunity, aiming to move beyond symptom control. Its lead candidate, telitacicept, is designed to silence the signals that allow harmful immune cells to survive. The company's objective is to deliver safer, longer-lasting therapies that address the source of autoimmune conditions.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the SEC regarding a Registration Statement on Form S-1 for Vor Biopharma Inc. It is a request by underwriters to accelerate the effective date of the Registration Statement under Rule 461 of the Securities Act of 1933. The content is procedural and relates to the timing of the registration statement becoming effective, not the registration statement itself or any financial data. The document is short (1965 characters) and is a formal request related to capital raising but does not provide details of financing activities or capital structure changes. This type of document is best classified as a Regulatory Filing (RNS) because it is a regulatory communication that does not fit into other specific categories such as Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA).
2021-02-02 English
Regulatory Filings 2021
Regulatory Filings Classification · 100% confidence The document is a letter from Vor Biopharma Inc. to the SEC requesting acceleration of effectiveness for a Registration Statement on Form S-1. It references Rule 461 under the Securities Act of 1933 and requests the SEC to make the Form S-1 effective by a certain date and time. This is a regulatory procedural filing related to the registration of securities, not a financial report, earnings release, or other types of filings. The document is short (1520 characters) and is a formal request rather than a report or announcement of results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory documents that do not fit other specific categories.
2021-02-02 English
8-A12B
Regulatory Filings Classification · 100% confidence The document is a Form 8-A filed with the SEC for registration of certain classes of securities pursuant to Section 12(b) or (g) of the Securities Exchange Act of 1934. It is a registration statement for common stock to be listed on Nasdaq. The document does not contain financial statements, earnings data, management discussion, or other report content. It is a regulatory filing related to securities registration, not an annual report, earnings release, or other financial report. The document length is 3282 characters, which is relatively short and consistent with a regulatory filing form. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-02-01 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The document is a response letter from a law firm to the SEC regarding comments on a Registration Statement on Form S-1 filed by Vor Biopharma Inc. It discusses amendments to the Form S-1 registration statement and addresses SEC staff comments. The document is not a financial report, earnings release, or any other type of report but rather a regulatory correspondence related to a registration statement filing. It is a regulatory filing that does not fit into other specific categories such as Annual Report, Earnings Release, or Proxy Solicitation. Therefore, it should be classified as a Regulatory Filing (RNS). The document length is 3673 characters, which is relatively short and consistent with a letter or regulatory correspondence rather than a full report.
2021-02-01 English
S-1/A
Regulatory Filings Classification · 100% confidence The document is a Form S-1/A Registration Statement Amendment No. 1 filed with the SEC for Vor Biopharma Inc. It is a regulatory filing related to the registration of securities for an initial public offering (IPO). The document includes detailed information about the company, the offering, risk factors, management discussion, financial data, and other disclosures typical of an S-1 registration statement. It is not an annual report, earnings release, or any other financial report type. It is a regulatory filing specific to securities registration under the Securities Act of 1933. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it is not merely an announcement or a short notice, so it is not a Report Publication Announcement (RPA).
2021-02-01 English
Regulatory Filings 2021
Regulatory Filings
2021-01-27 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.